Hematology/Oncology

Top Story

High-dose vitamin C may increase efficacy of cancer therapies

High-dose vitamin C may increase efficacy of cancer therapies
June 23, 2017

The addition of high-dose vitamin C to standard chemotherapy or radiation appeared to effective and safe for patients with glioblastoma multiforme and non–small cell lung cancer, according to study results.

Prior studies that assessed use of vitamin C in combination with chemotherapy and radiation yielded conflicting data.

Focused Ultrasound Foundation, Cancer Research Institute partner to advance immunotherapy research

June 23, 2017
Focused Ultrasound Foundation and Cancer Research Institute will partner to advance the research and development of new focused ultrasound and cancer immunotherapy…
Meeting NewsVideo

VIDEO: Adam Brufsky, MD, PhD, discusses results of MONARCH-2, PALOMA-1 trials

June 23, 2017
Adam M. Brufsky, MD, PhD, professor of medicine and co-director of the Comprehensive Breast Cancer Center at the University of Pittsburgh, discusses the results of the…
Meeting NewsVideo

VIDEO: High-intensity genomic assay may help ‘unlock mysteries’ in lung cancer treatment

June 23, 2017
CHICAGO — Edward S. Kim, MD, chair of solid tumor oncology and investigational therapeutics at the Levine Cancer Institute, and a HemOnc Today Editorial Board…
FDA News

FDA approves Tafinlar plus Mekinist for BRAF V600E–mutant non–small cell lung cancer

June 22, 2017
The FDA approved use of dabrafenib in combination with trametinib for treatment of patients with metastatic non–small cell lung cancer whose tumors harbor BRAF
More News Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: High-intensity genomic assay may help ‘unlock mysteries’ in lung cancer treatment

June 23, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement